Glycomimetics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of glycomimetics, inc. - glyc

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of glycomimetics, inc. (nasdaqgm: glyc) and crescent biopharma, inc. pursuant to the terms of the agreement, shareholders of glycomimetics will own approximately 3.1% of the combined company. ksf is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fai.
GM Ratings Summary
Quant
GM Quant Ranking
Sector
Industry
Quant Rating
Quant Score